Phenanthroline bridged bis(β-cyclodextrin)s/adamantane-carboxylic acid supramolecular complex as an efficient fluorescence sensor to Zn2+

Yu-Hui Zhang , Ying-Ming Zhang , Yong Chen , Yang Yang and Yu Liu *
Department of Chemistry, State Key Laboratory of Elemento-Organic Chemistry, Nankai University, Collaborative Innovation Center of Chemical Science and Engineering, Tianjin 300071, P. R. China. E-mail: yuliu@nankai.edu.cn

Received 25th November 2013 , Accepted 18th February 2014

First published on 17th March 2014


Abstract

A water-soluble fluorescent Zn2+ sensor, 1,10-phenanthroline bridged bis(β-cyclodextrin) (1), was synthesized by “click chemistry”, and its fluorescence sensing behavior toward Zn2+ against various metal ions was investigated under physiological conditions. Significantly, 1 showed high selectivity and sensitivity toward Zn2+ with a limit of detection (LOD) down to 10−7 M. Moreover, the spectrophotometric studies demonstrated that after complexation with 1-admantanecarboxylic acid sodium salt (AdCA), the 1/AdCA complex gave much stronger binding affinity and lower LOD value toward Zn2+ through a cyclodextrin/substrate/Zn2+ triple recognition mode. The fluorescence stopped-flow experiments also indicated that the association rate of complex 1/AdCA to Zn2+ was much faster than compound 1 to the same ion. Furthermore, the fluorescence intensity of 1 and 1/AdCA was greatly enhanced after binding Zn2+ in living cells, and thus 1 and complex 1/AdCA could be considered as a biosensor for Zn2+ at the cellular level.


Introduction

The fluorescence sensing of Zn2+ in water has drawn more and more attention in recent years, because Zn2+ is closely related to our biomedical and physiological events.1 As the second most abundant transition metal in the human body, Zn2+ plays an important role in many kinds of biological processes, such as brain function and pathology, gene transcription, metalloenzyme regulation, immune function, and neural signal transmission.2 Therefore, it is an increasingly significant topic to quantitatively detect Zn2+ under physiological conditions. However, the zinc ion itself is spectroscopically silent due to its 3d104s0 electronic configuration, which seriously hinders the real-time monitoring of Zn2+ in biological systems.3 To solve this problem, a large number of fluorescent probes have been developed and exhibit excellent Zn2+ responsiveness in vitro and in vivo, mainly due to their immense advantages of simplicity, high sensitivity and selectivity, instantaneous response, and local observation.4 Nevertheless, among these fluorescent Zn2+ chemosensors, only few of them are totally water-soluble and can detect Zn2+ without disturbance from Cd2+.5

Cyclodextrins (CDs), a class of cyclic oligosaccharides possessing a hydrophobic cavity, are widely used as drug carriers and solubilizers.6 The modification of the CD backbone with chromophoric substituents has been proven as a more powerful strategy in the fluorescence sensing of transition- or heavy-metal ions. For instance, we have constructed a series of CD-based switch-on fluorescent sensors for Zn2+, Cd2+, and Hg2+, showing satisfactory molecular selectivity and enhanced binding abilities in aqueous solution, thin film, and living cells.7 In the present work, phenanthroline is connected with β-CD to obtain 1,10-phenanthroline bridged bis(β-CD) 1 by “click chemistry”, which showed satisfactory water solubility and high fluorescence sensing efficiency for Zn2+. The two adjacent CD cavities in 1 could not only act as an ideal solubilizer, but also endowed the phenanthroline core with cell permeability through the interaction of β-CD with the phospholipids and cholesterol on the cell membrane.8 Moreover, due to the strong association of the β-CD cavity with the adamantyl skeleton, 1 could form a stable inclusion complex with 1-admantanecarboxylic acid sodium salt (AdCA), and the resultant 1/AdCA complex exhibited much stronger binding ability, lower limit of detection (LOD) value, and faster reaction rate toward Zn2+. Our obtained results will energize the potential use of CD-based bioactive nanosupramolecules in the construction of efficient fluorescence sensors with actual device implementation.

Results and discussion

Synthesis

The synthetic route to compound 1 is described in Scheme 1. Compound 1 was synthesized via “click chemistry” between 2,9-dipropargyl-1,10-phenanthroline and mono(6-deoxyl-6-azido)-β-CD9 in 28% yield, and was sufficiently characterized by NMR spectroscopy, MALDI-MS, and elemental analysis (Fig. S1–S6 in the ESI). Benefiting from the good solubilization ability of two adjacent β-CD units, the host compound 1 showed a satisfactory solubility up to 0.05 M in water.
image file: c3qo00054k-s1.tif
Scheme 1 Synthetic route of compound 1.

Fluorescence sensing of Zn2+ by 1

The fluorescence sensing behavior of 1 toward Zn2+ was investigated by means of fluorescence spectroscopy in HEPES buffer solution (10 mM, pH = 7.2) at 25 °C. As shown in Fig. 1, compound 1 showed a good fluorescence sensing ability for Zn2+. The emission intensity of 1 at 377 nm gradually increased upon addition of Zn2+, accompanied by an obvious bathochromic shift from 368 to 377 nm. Furthermore, a maximum peak at a molar fraction of 0.5 was clearly observed in the Job plot, corresponding to a 1[thin space (1/6-em)]:[thin space (1/6-em)]1 coordination stoichiometry between 1 and Zn2+ (Fig. 2). After validating the 1[thin space (1/6-em)]:[thin space (1/6-em)]1 1/Zn2+ stoichiometry, the binding constant (log KS) between 1 and Zn2+ could be calculated as 5.95 using a nonlinear least-squares curve-fitting method by analyzing the sequential changes in fluorescence intensity (ΔF) of 1 in the presence of varying concentrations of Zn2+.10 In addition, the limit of detection (defined as LOD value) of 1 to Zn2+ was measured as 4.92 × 10−7 M by multiplying the standard derivation of 11 groups of blank measurements by 3 and then dividing by the slope of the linear calibration curve at the lower concentration range of Zn2+.11
image file: c3qo00054k-f1.tif
Fig. 1 Fluorescence spectral changes of 1 (1.5 × 10−5 M) upon addition of Zn(ClO4)2 (0, 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, and 36 × 10−6 M, from a to m) in HEPES buffer solution (10 mM, pH = 7.2). Inset: the nonlinear least-squares analysis of the differential fluorescence intensity (ΔF) with the concentration of Zn2+ to calculate the binding constant (KS) (λex = 272 nm and λem = 377 nm).

image file: c3qo00054k-f2.tif
Fig. 2 Job plot of 1/Zn2+ system in HEPES buffer solution (10 mM, pH = 7.2) at 25 °C ([1] + [Zn2+] = 2.0 × 10−5 M).

The possible mechanism for the enhanced fluorescence of 1/Zn2+ complex may originate from a controlled intramolecular photo-induced electron transfer (PET) process; that is, before coordination with Zn2+, the PET process takes place from the 1,2,3-triazole moiety as an electron-rich donor to the phenanthroline moiety as an electron-deficient acceptor. After coordination with Zn2+, the nonradiative channel in the PET process was synchronously suppressed to a great extent, ultimately leading to a pronounced emission intensity of the phenanthroline fluorophore. Moreover, a favorable size/shape fit was achieved between the ionic radius of Zn2+ and the semi-rigid structure of the phenanthroline and triazole units to form a five-membered chelating ring.

Comparatively, the fluorescence sensing selectivity of 1 toward various metal cations was also studied in a physiological environment. As shown in Fig. 3, the fluorescence of 1 showed a 2.1-fold fluorescence enhancement in the presence of 2 equiv. of Zn2+, but its IIB homologue Cd2+ only gave a negligible change under the same experimental conditions. Moreover, an obvious fluorescence quenching was observed when Ag+, Co2+, Cu2+, Hg2+, and Pb2+ were added into the solution of 1. These phenomena may be ascribable to the electron or energy transfer from the phenanthroline moiety of 1 to the unfilled electronic orbitals on these cations.


image file: c3qo00054k-f3.tif
Fig. 3 Fluorescence change (ΔF/F0) of 1 at 377 nm in the presence of different metal cations in HEPES buffer (10 mM, pH = 7.2). ([1] = 1.5 × 10−5 M, [Mn+] = 3.0 × 10−5 M, λex = 272 nm).

Fluorescence sensing of 1/AdCA to Zn2+

It is well-documented that there is a high affinity between the cavity of β-CD and adamantane derivatives with KS values up to 104 M−1. In the present work, 1-admantanecarboxylic acid sodium salt (AdCA) was employed to investigate the enhanced Zn2+ binding stability and sensing ability of the 1/AdCA inclusion complex (Fig. 4). In comparison to the fluorescence quenching with Cd2+, it was found that the fluorescence intensity of 1/AdCA was exclusively enhanced with Zn2+ (Fig. S7). Similar to the 1/Zn2+ system, the 1[thin space (1/6-em)]:[thin space (1/6-em)]1 coordination stoichiometry between 1/AdCA and Zn2+ was confirmed by a Job plot (Fig. S8). Therefore, using the fluorescence titration method, the log KS value of 1/AdCA with Zn2+ was calculated as 7.74, which was almost 100 times higher than the corresponding value of 1 with Zn2+. Meanwhile, a relatively lower LOD value was also obtained as 3.38 × 10−7 M in 1/AdCA to Zn2+.
image file: c3qo00054k-f4.tif
Fig. 4 Fluorescence emission spectra of 1 (1.5 × 10−5 M)/AdCA upon addition of Zn(ClO4)2 (0, 3, 6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36 × 10−6 M from a to m) in HEPES buffer solution (10 mM, pH = 7.2). Inset: the nonlinear least-squares analysis of the differential fluorescence intensity (ΔF) with the concentration of Zn2+ to calculate the complex binding constant (KS) (λex = 272 nm, λem = 377 nm).

Binding mode

The binding modes of 1 and 1/AdCA with Zn2+ were studied by means of 1H NMR, fluorescence spectroscopy, and circular dichroism spectroscopy. As shown in Fig. 5, the protons of the phenanthroline and triazole moieties of 1 exhibited a downfield shift (Δδ) in the presence of Zn2+δa,1 = 0.37 ppm, Δδb,1 = 0.04 ppm, Δδc,1 = 0.29 ppm, and Δδd,1 = 0.18 ppm), indicative of the electron deshielding effect of metal ions on the adjacent protons. Thus, we could deduce that the phenanthroline and triazole moieties of 1 participated in the coordination process with Zn2+. Moreover, by employing a Hill plot,11 the binding stoichiometry and log KS value between 1 and AdCA could be fitted as 2 and 4.2 × 106 M−2, respectively, indicating that two AdCA units were concurrently encapsulated in the CD cavities to form a 2[thin space (1/6-em)]:[thin space (1/6-em)]1 complex with high affinity (Fig. S9 and S10 in the ESI). Based on this binding constant, we can calculate that more than 90% of 1 was changed to the 1/AdCA complex under our experimental conditions, and both CD cavities of 1 were occupied by AdCA to jointly coordinate with Zn2+. In addition, the fluorescence sensing of Zn2+ was investigated with ca. 50% and 90% 1/AdCA encapsulation ratios. As the AdCA encapsulation ratio increases, it is found that the fluorescence intensity of the 1/AdCA/Zn2+ ternary complex decreases accordingly (Fig. S11 in the ESI). This result indicates that as compared with free host 1 and the 1[thin space (1/6-em)]:[thin space (1/6-em)]1 1/AdCA complex, the introduction of more AdCA can induce a slight fluorescent quenching in the coordination process.
image file: c3qo00054k-f5.tif
Fig. 5 1H NMR spectra of (a) 1 and (b) 1/Zn2+ complex using DMSO as internal standard in D2O at 25 °C ([1] = 1.0 × 10−3 M and [Zn2+] = 2.0 × 10−3 M).

Furthermore, 2D NMR spectroscopic experiments were performed to obtain structural information on the host–guest complexation. As shown in Fig. S12, the nuclear Overhauser enhancement (NOE) cross-correlations between the protons of the 1,2,3-triazole ring and the H5 protons of the β-CD (peaks A), as well as those between the protons of the phenanthroline group and the H3 protons of the β-CD (peaks B and C), jointly demonstrate that the phenanthroline moiety of 1 was partially accommodated in the cavity of β-CD from its primary face. After adding 2 equiv. of Zn2+, it was found that the phenanthroline spacer of 1 was still self-included in the cavity of β-CD (Fig. S13 in the ESI). In contrast, clear NOE correlations between the protons of AdCA and the interior protons of β-CD (H3/H5/H6) were observed (peaks A), and all the self-inclusion cross-peaks between phenanthroline and the CD cavity disappeared in the ternary complex of 1/AdCA/Zn2+ (Fig. S14 in the ESI). In addition, the AdCA protons showed a stronger NOE correlation with H5/H6 than the H3 protons of β-CD. Considering that the H5/H6 protons are located near the narrow opening and the H3 protons are located near the wide opening of the β-CD cavity, we can infer that AdCA was preferentially located in the narrow opening and then drove the phenanthroline unit of 1 out of the cavity.

As shown in Fig. 6, the host 1 gave two induced circular dichroism (ICD) signals in aqueous solution. Based on the empirical rules for the ICD behavior of CD inclusion complexes,12 the positive Cotton effect peak (Δε = 5.31 M−1 cm−1) at 230 nm and the negative one (Δε = −6.11 M−1 cm−1) at 272 nm reveal that the phenanthroline group is partially self-included in the chiral microenvironment of the β-CD cavity, which is in accordance with the intramolecular self-inclusion mode in the 2D NMR spectroscopic experiment. Moreover, it is found that the Cotton peak intensity of 1 slightly decreased in the presence of Zn2+ or AdCA, mainly because the phenanthroline moiety was gradually released from the β-CD cavity. Conversely, when both Zn2+ and AdCA coexisted, the ICD signals of 1 was reversed from a negative Cotton peak to a strong positive one, accompanied by enhanced signal intensity from Δε = −3.48 M−1 cm−1 to Δε = 27.89 M−1 cm−1 at 278 nm. These phenomena indicate that there is a conformational change upon complexation of 1 with Zn2+ and AdCA. Due to the supramolecular cooperativity between CD and AdCA, the phenanthroline unit of 1 was forced out of the β-CD cavity to facilitate the multivalent binding of the phenanthroline, triazole, and carboxylic sites with Zn2+.13 Consequently, combining all the characteristic data from NMR and circular dichroism spectroscopy, we can reasonably deduce the possible binding modes of 1/Zn2+ and 1/AdCA/Zn2+, as illustrated in Scheme 2. In addition, the energy minimization structure of the 1/AdCA/Zn2+ system was obtained by a molecular modeling study, which is consistent with the proposed recognition mode (Fig. S15 in the ESI).


image file: c3qo00054k-f6.tif
Fig. 6 Circular dichroism spectra of (a) 1, (b) 1/AdCA complex, (c) 1/Zn2+ complex, and (d) 1/AdCA/Zn2+ complex in HEPES buffer solution at 25 °C ([1] = 1.5 × 10−5 M, [Zn2+] = 3 × 10−5 M, and [AdCA] = 1 × 10−3 M).

image file: c3qo00054k-s2.tif
Scheme 2 The possible binding modes of 1/Zn2+ and 1/AdCA/Zn2+ systems.

Binding dynamics

The binding dynamics for the association of 1 and 1/AdCA with Zn2+ were further measured by fluorescence stopped-flow experiments, in which the dynamic data can be simplified as a pseudo-first-order reaction in the presence of excess amounts of Zn2+. The observed reaction rate constant (kobs) could be determined by linear regression at different concentrations of Zn2+.14
 
image file: c3qo00054k-t1.tif(1)
 
image file: c3qo00054k-t2.tif(2)
 
kobs = k+i[Zn2+] + ki (i = 1, 2)(3)
where k+i and ki are the rate constants for the forward and backward reactions for 1 and 1/AdCA with Zn2+, respectively. In the stopped-flow experiments, the values of k+1 and k+2 were measured as 3.94 × 105 M−1 s−1 and 1.46 × 106 M−1 s−1, respectively (Fig. 7 and Fig. S16), indicating that the association rate of 1/AdCA with Zn2+ was much faster than that of 1 with Zn2+. This is reasonable, because there are more binding sites in 1/AdCA to accelerate the coordination of Zn2+ in aqueous solution.

image file: c3qo00054k-f7.tif
Fig. 7 Dependence of observed rate constant kobs of 1 (1.5 × 10−5 M) with different concentrations of Zn2+ in HEPES buffer solution (10 mM, pH = 7.2). Inset: dynamic experiments of the rapid mixing of 1 (1.5 × 10−5 M) with different concentrations of Zn(ClO4)2 (0, 0.75, 1.5, 2.25, 3.0, and 3.75 × 10−4 M). All concentrations mentioned above are final ones after mixing.

Confocal fluorescent images in vitro

To gain more insight into the practical application of 1 and its corresponding supramolecular complex 1/AdCA, the fluorescence sensing behaviors of 1 and 1/AdCA toward Zn2+ were studied in vitro by confocal fluorescent microscopy using HeLa human cervical carcinoma cells as the model cell line. As shown in Fig. 8a–c, the HeLa cells exhibited a weak blue fluorescence after incubation with 1 alone at 37 °C for 3 h, but a strong blue fluorescence was observed when the same cells were pretreated with Zn2+ for 0.5 h and then incubated with 1 for 3 h (Fig. 8d–f). A similar phenomenon was also observed in the case of 1/AdCA/Zn2+ system (Fig. 8g–i). These results indicate that, combined with their cell permeability and biocompatibility, 1 and 1/AdCA could be used as the potential sensors for intracellular Zn2+ detection.
image file: c3qo00054k-f8.tif
Fig. 8 Confocal fluorescence images of HeLa cells. (a)–(c) Cells incubated in the presence of 1 for 3 h; (d)–(f) cells pretreated with Zn2+ for 0.5 h then incubated in the presence of 1 for 3 h; (g)–(i) cells pretreated with Zn2+ for 0.5 h then incubated in the presence of 1 and AdCA for 3 h. (a), (d), and (g): Bright field images; (b), (e), and (h): fluorescence images; and (c), (f), and (i): merged images ([1] = 5 × 10−5 M, [AdCA] = 5.7 × 10−4 M, [Zn2+] = 1 × 10−4 M, and scale bar = 5 μm).

Conclusion

In conclusion, we successfully synthesized a water-soluble fluorescent Zn2+ sensor 1 by “click chemistry”. As investigated by fluorescent titration, it exhibited high selectivity and sensitivity toward Zn2+ with a 1[thin space (1/6-em)]:[thin space (1/6-em)]1 binding mode. Study of the binding mode further revealed that the cooperative coordination of phenanthroline and triazole moieties played an indispensable role in the fluorescence sensing of Zn2+. Superior to 1, the 1/AdCA system showed much stronger binding affinity, lower LOD value, and faster association rate toward Zn2+ in aqueous solution. The confocal fluorescent images demonstrated that 1 and 1/AdCA were cell-permeable and could effectively detect intracellular Zn2+ at cellular level. Although the sensitivity toward Zn2+ in the present work is moderate, the design strategy may act as a general and versatile platform to create an effective fluorescence Zn2+ sensor with a longer emission wavelength. Considering the immense advantages in preparation, water solubility, and sensing specificity for Zn2+, we also envision that the 1,10-phenanthroline bridged bis(β-CD) and its AdCA complex may have great application prospects in biological and environmental science and technology.

Experimental section

Synthesis of 1,10-phenanthroline bridged bis(β-CD) (1)

2,9-Bis(hydroxymethyl)-1,10-phenanthroline (90 mg, 0.285 mmol) in 10 mL THF was added to a solution of mono(6-deoxyl-6-azido)-β-cyclodextrin (1.65 g, 1.42 mmol) in 35 mL water, then CuSO4·5H2O (710 mg, 2.84 mmol) and sodium ascorbate (1.4 g, 7.11 mmol) were added into the above solution. The mixture was heated at 50 °C under an atmosphere of N2 for 2 days. The precipitate was filtered, and the filtrate was dried under reduced pressure. The residue was dissolved in a small amount of water, poured into 300 mL acetone and stirred, and then this process was repeated 3 times. Column chromatography using n-PrOH–H2O–25% NH3·H2O (6[thin space (1/6-em)]:[thin space (1/6-em)]3[thin space (1/6-em)]:[thin space (1/6-em)]2 v/v/v) as eluent yielded the crude product. Next, the crude product was further purified by MPLC (reversed phase) with water–ethanol (85[thin space (1/6-em)]:[thin space (1/6-em)]15 v/v) as eluent to give 1 as a pale yellow solid (240.7 mg, 28% yield). 1H NMR (400 MHz, D2O, ppm): δ = 3.27–3.98 (m, 84H, H of C-3, C-5, C-6, C-2, C-4 of β-CD), 4.83 (d, J = 4 Hz, 4H, –CH2–), 4.89 (s, 4H, –CH2–), 4.97–5.10 (m, 14H, H of C-1 of β-CD), 7.72–7.75 (m, 4H, H of phenanthroline and triazole), 8.10 (s, 2H, H of phenanthroline), 8.31 (d, J = 8 Hz, 2H, H of phenanthroline); 13C NMR (100 MHz, D2O, ppm): δ = 56.1, 64.2, 65.2, 68.4, 76.3, 76.7, 77.0, 78.0, 86.1, 88.0, 106.4, 106.8, 126.8, 131.3, 131.8, 132.9, 142.7, 148.5, 148.8, 162.3 ppm; MALDI-TOF MS: m/z: 2636.88 [M + H]+, 2658.87 [M + Na]+; elemental analysis calcd (%) for C104H154N8O70·19H2O: C 41.94; H 6.50; N 3.76; found: C 41.85; H 6.40; N 4.10.

Acknowledgements

We thank 973 Program (2011CB932502) and NNSFC (91227107, 21272125 and 21102075) for financial support.

References

  1. (a) T. Hirano, K. Kikuchi, Y. Urano, T. Higuchi and T. Nagano, J. Am. Chem. Soc., 2000, 122, 12399–12400 CrossRef CAS; (b) Z. Xu, K.-H. Baek, H. N. Kim, J. Cui, X. Qian, D. R. Spring, I. Shin and J. Yoon, J. Am. Chem. Soc., 2010, 132, 601–610 CrossRef CAS PubMed; (c) H. A. Godwin and J. M. Berg, J. Am. Chem. Soc., 1996, 118, 6514–6515 CrossRef CAS; (d) N. C. Lim, H. C. Freake and C. Brückner, Chem.–Eur. J., 2005, 11, 38–49 CrossRef PubMed; (e) E. Kimura and S. Aoki, BioMetals, 2001, 14, 191–204 CrossRef CAS.
  2. (a) C. J. Frederickson, J.-Y. Koh and A. I. Bush, Nat. Rev. Neurosci., 2005, 6, 449–462 CrossRef CAS PubMed; (b) P. Jiang and Z. Guo, Coord. Chem. Rev., 2004, 248, 205–229 CrossRef CAS PubMed; (c) Y.-H. Zhou, M. Zhao, Z.-W. Mao and L.-N. Ji, Chem.–Eur. J., 2008, 14, 7193–7201 CrossRef CAS PubMed; (d) N. P. Pavletich and C. O. Pabo, Science, 1991, 252, 809–817 CrossRef CAS; (e) P. J. Fraker and L. E. King, Annu. Rev. Nutr., 2004, 24, 277–298 CrossRef CAS PubMed; (f) S. Yamasaki, K. Sakata-Sogawa, A. Hasegawa, T. Suzuki, K. Kabu, E. Sato, T. Kurosaki, S. Yamashita, M. Tokunaga, K. Nishida and T. Hirano, J. Cell Biol., 2007, 177, 637–645 CrossRef CAS PubMed; (g) T. V. O'Halloran, Science, 1993, 261, 715–725 CAS.
  3. (a) F. A. Cotton and G. Wilkinson, Advanced Inorganic Chemistry, John Wiley & Sons, New York, 4th edn, 1980 Search PubMed; (b) M. Li, H.-Y. Lu, R.-L. Liu, J.-D. Chen and C.-F. Chen, J. Org. Chem., 2012, 77, 3670–3673 CrossRef CAS PubMed.
  4. (a) K. Komatsu, Y. Urano, H. Kojima and T. Nagano, J. Am. Chem. Soc., 2007, 129, 13447–13454 CrossRef CAS PubMed; (b) F. Qian, C. Zhang, Y. Zhang, W. He, X. Gao, P. Hu and Z. Guo, J. Am. Chem. Soc., 2009, 131, 1460–1468 CrossRef CAS PubMed; (c) S. Atilgan, T. Ozdemir and E. U. Akkaya, Org. Lett., 2008, 10, 4065–4067 CrossRef CAS PubMed.
  5. (a) J. Yuasa, A. Mitsui and T. Kawai, Chem. Commun., 2011, 47, 5807–5809 RSC; (b) Y. Zhang, X. Guo, W. Si, L. Jia and X. Qian, Org. Lett., 2008, 10, 473–476 CrossRef CAS PubMed; (c) L. Xue, C. Liu and H. Jiang, Org. Lett., 2009, 11, 1655–1658 CrossRef CAS PubMed.
  6. (a) Y. Yang, Y.-M. Zhang, Y. Chen, D. Zhao, J.-T. Chen and Y. Liu, Chem.–Eur. J., 2012, 18, 4208–4215 CrossRef CAS PubMed; (b) K. Uekama, F. Hirayama and T. Irie, Chem. Rev., 1998, 98, 2045–2076 CrossRef CAS PubMed.
  7. (a) Y. Liu, N. Zhang, Y. Chen and L.-H. Wang, Org. Lett., 2007, 9, 315–318 CrossRef CAS PubMed; (b) Y. Liu, M. Yu, Y. Chen and N. Zhang, Bioorg. Med. Chem., 2009, 17, 3887–3891 CrossRef CAS PubMed; (c) Y.-M. Zhang, Y. Chen, Z.-Q. Li, N. Li and Y. Liu, Bioorg. Med. Chem., 2010, 18, 1415–1420 CrossRef CAS PubMed; (d) Y. Chen, Z.-H. Sun, B.-E. Song and Y. Liu, Org. Biomol. Chem., 2011, 9, 5530–5534 RSC; (e) B.-W. Liu, Y. Chen, B.-E. Song and Y. Liu, Chem. Commun., 2011, 47, 4418–4420 RSC.
  8. T. Irie and K. Uekama, Adv. Drug Delivery Rev., 1999, 36, 101–123 CrossRef CAS.
  9. C. Hocquelet, J. Blu, C. K. Jankowski, S. Arseneau, D. Buisson and L. Mauclaire, Tetrahedron, 2006, 62, 11963–11971 CrossRef CAS PubMed.
  10. (a) Y. Liu, Y. Song, Y. Chen, X.-Q. Li, F. Ding and R.-Q. Zhong, Chem.–Eur. J., 2004, 10, 3685–3696 CrossRef CAS PubMed; (b) Y. Liu, H.-M. Yu, Y. Chen and Y.-L. Zhao, Chem.–Eur. J., 2006, 12, 3858–3868 CrossRef CAS PubMed; (c) Y. Liu, J. Shi and D.-S. Guo, J. Org. Chem., 2007, 72, 8227–8234 CrossRef CAS PubMed.
  11. X.-L. Tang, X.-H. Peng, W. Dou, J. Mao, J.-R. Zheng, W.-W. Qin, W.-S. Liu, J. Chang and X.-J. Yao, Org. Lett., 2008, 10, 3653–3656 CrossRef CAS PubMed.
  12. M. Kajtár, C. Horvath-Toro, E. Kuthi and J. Szejtli, Acta Chim. Acad. Sci. Hung., 1982, 110, 327–355 Search PubMed.
  13. B. Balan and K. R. Gopidas, Chem.–Eur. J., 2007, 13, 5173–5185 CrossRef CAS PubMed.
  14. E. Bombarda, B. P. Roques, Y. Mély and E. Grell, Biochemistry, 2005, 44, 7315–7325 CrossRef CAS PubMed.

Footnote

Electronic supplementary information (ESI) available: Experimental methods, synthetic routes and characterization of compounds 1 and 2, Job plots of 1/Zn2+ and 1/AdCA/Zn2+ systems, the fluorescence changes (ΔF/F0) of 1 in the presence of different metal cations, as well as 2D NOESY spectra of 1/AdCA/Zn2+ system. See DOI: 10.1039/c3qo00054k

This journal is © the Partner Organisations 2014